Abu Dhabi's Sheikh Khalifa Medical City, Cleveland Clinic Abu Dhabi, and Burjeel Medical City serve a diverse patient population including Abu Dhabi's large South Asian and Southeast Asian expatriate communities — many of whom are at elevated COVID-19 risk from diabetes, hypertension, and other metabolic conditions highly prevalent in these groups. Molnulee from Unnati Pharmax provides Abu Dhabi private clinics and pharmacies with reliable, affordable Molnupiravir supply.
Abu Dhabi's status as the UAE's administrative capital and home to significant governmental and diplomatic communities creates demand for both institutional and private individual COVID antiviral access. Generic Molnulee at significantly lower cost than brand Lagevrio makes timely COVID treatment initiation financially accessible for Abu Dhabi's working-class expatriate population.
Visit medshopy.com or WhatsApp +91 82650 41513 for Abu Dhabi and UAE Capital supply.
Abu Dhabi's status as the UAE's administrative capital and home to significant governmental and diplomatic communities creates demand for both institutional and private individual COVID antiviral access. Generic Molnulee at significantly lower cost than brand Lagevrio makes timely COVID treatment initiation financially accessible for Abu Dhabi's working-class expatriate population.
Visit medshopy.com or WhatsApp +91 82650 41513 for Abu Dhabi and UAE Capital supply.
Should I take Molnulee even if my COVID symptoms seem mild — how do I know if I need it?Molnupiravir (Molnulee) is not recommended for every COVID-positive person — it's specifically indicated for adults at high risk of progressing to severe disease who do not require immediate hospitalisation. High-risk indicators include: age over 60, obesity (BMI above 30), diabetes mellitus, cardiovascular disease, chronic lung disease, chronic kidney disease, immunocompromised status (HIV, cancer treatment, organ transplant), or other significant comorbidities. Even if symptoms feel mild at the time of diagnosis, high-risk individuals should start antiviral therapy promptly — because COVID progression to severe disease can happen quickly, and Molnupiravir works best when started early (within 5 days of symptom onset). If you have multiple risk factors, contact your Abu Dhabi physician on the day of your positive test.
